Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE | CERAMEDIX HOLDING, LLC | $4,223,612 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jun 29, 2023 | Jul 1, 2023 | Jun 30, 2027 | ||
| JW190496 FY19 NEW START | CERAMEDIX HOLDING, LLC | $4,496,897 | DEFENSE HEALTH AGENCY (DHA) | DEFENSE HEALTH AGENCY (DHA) | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN93 | Sep 25, 2020 | Sep 28, 2020 | Sep 27, 2024 |